NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Emergent Biosolutions (EBS) Technical (Analysis) Reports Emergent Biosolutions ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Emergent Biosolutions (EBS)

Technical Analysis Report for NYSE stock EBS Emergent Biosolutions. Dated: 16 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange

If you are looking for Tomorrow's Movement Predictions for NYSE stock EBS Emergent Biosolutions then click here. or read Experts views on Emergent Biosolutions or Forecast & share price targets of Emergent Biosolutions

Emergent Biosolutions Opened at 11.01 and Closed at: 10.99, which is 0.45% of previous session's close. It moved within a range of 10.90 and 11.47
The session was a Bearish session with an average volume of 1726200, which is 14.13% of previous session's volumes.

• There is some positive change in the mid term trend, but its too soon to jump onto conclusions.
• The stock has shown an up move, and its long term trend is also positive and in an uptrend.

Support for tomorrow is 10.66 and resistance for tomorrow is 11.23
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 10.77, 10.55 resistance for tomorrow's hourly charts is 11.34, 11.69

10 Day SMA for Emergent Biosolutions (EBS) is 12.53 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Emergent Biosolutions (EBS) is 12.48 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Emergent Biosolutions (EBS) is 11.58 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 10.3 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Emergent Biosolutions is 8.37 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Emergent Biosolutions is at 12.48 and 200 DMA is at 8.37, while 50 DMA and 100 DMA are at 11.58 and 10.3 respectively

Emergent Biosolutions (EBS) moving average of 20 SMA is at 12.48 and 20 EMA is at 12.21

Emergent Biosolutions (EBS) moving average of 50 SMA is at 11.58 and 50 EMA is at 11.62

Emergent Biosolutions (EBS) moving average of 100 SMA is at 10.3 and 100 EMA is at 10.58

Emergent Biosolutions (EBS) moving average of 200 SMA is at 8.37 and 200 EMA is at 9.57

U S has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in U S, about 19.9% more returns!

Unitedhealth Group has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Unitedhealth Group, about 11.55% more returns!

Tenet Healthcare has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Tenet Healthcare, about 11.87% more returns!

Stryker Corporation has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Stryker Corporation, about 13.67% more returns!

Arcus Biosciences has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Arcus Biosciences, about 9.79% more returns!

Abbvie Inc has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Abbvie Inc, about 6.85% more returns!

Brookdale Senior has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Brookdale Senior, about 24.99% more returns!

Bristol Myers has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Bristol Myers, about 14.31% more returns!

Boston Scientific has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Boston Scientific, about 2.28% more returns!

Civitas Solutions has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Civitas Solutions, about 8.39% more returns!

Community Health has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Community Health, about 10.03% more returns!

Glaxosmithkline Plc has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 10.51% more returns!

Hca Healthcare has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Hca Healthcare, about 11.24% more returns!

Molina Healthcare has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Molina Healthcare, about 28.3% more returns!

Merck Company has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Merck Company, about 18.7% more returns!

Penumbra Inc has performed better than Emergent Biosolutions in short term. You could have earned much better returns by investing in Penumbra Inc, about 21.88% more returns!

Emergent Biosolutions Technical analysis of indicators

Price action analysis of Emergent Biosolutions (EBS) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for Emergent Biosolutions stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Emergent Biosolutions in short term but the sell signal is initial and weak.

Emergent Biosolutions Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up

CCI has generated a SELL signal for Emergent Biosolutions in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Emergent Biosolutions is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 12.37 and Emergent Biosolutions EBS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Emergent Biosolutions EBS stock. Volume based technical analysis of Emergent Biosolutions EBS stock is negative.

Emergent Biosolutions Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NYSE stock EBS Emergent Biosolutions These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And EBS Experts View which covers a lot of information including buying and selling signals

EBS future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Emergent Biosolutions or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet